You are in: Submissions
> Select unit of assessment
> UOA 12 Allied Health Professions and Studies
> University of East London
UOA 12 - Allied Health Professions and Studies
University of East London
RA5a: Research environment and esteem
Since the last RAE, the University has taken the opportunity to implement a strategy of substantial investment and development of research in Allied Health Professions and Studies mainly building on the legacy from Physiotherapy and Health Studies groups. This has been evidenced by actively recruiting more research active staff during the assessment period and the establishment of a new Institute of Health and Human Development (IHHD) in 2005-6. This Research Institute brings together individuals from areas of community health, physiotherapy, health psychology, podiatry and biomedical sciences. In addition to successfully raising core funding for the next 5 years, it continues the development of research at both national and international level, while establishing itself as the research partner of choice for local user-based NHS and health and social care delivery agencies.
One mark of the success of this strategy is the established and sustainable research environment, which has attracted high-calibre research active staff such as the two new professors (Renton and Turner) and four new research-focused early career researchers (ECRs) recruited since 2003 (Ahluwalia, Cahill, Corcoran and Petterson). All possess a track record of high impact publication and winning grants (collectively ca £7m since 2001 at other institutions). Other key developments in this period include over £1.8m income in successful bids since July 2007 and a substantive research output (a total of over 140 internationally peer reviewed publications by Category A staff in the full RAE period with @50% of papers submitted here, appearing after 2005). The success in publication is accompanied by Category A staff taking leading roles in European COST actions (Cutler), participation on NIH postgraduate/postdoctoral training programmes at USA centres (Drechsler, Turner), grants (Renton), and informing national and international Health Policy (Aceijas, Renton, Turner). Collectively, these achievements are evidence of rapid substantial and sustainable growth in the quality and quantity of funded research undertaken in the IHHD. The exponential increase in PhD supervisions undertaken by Category A staff since 2005 will also lead to a substantial increase in PhD completions in the next 24 months.
RESEARCH STUDENTS AND STUDENTSHIPS
Since 2005, the majority of PhDs have been funded internally as part of the development strategy for IHHD, notwithstanding the externally funded PhD studentships for example by The Haemophilia Society (Drechsler). Furthermore, the School trains large numbers of MSc students in research each year and the IHHD is incorporating progression of the most successful students onto PhDs. Each postgraduate research student is supported by the University's Graduate School Training Programme (rated excellent in the 2005-6 QAA review) and which conforms to the Research Councils' Joint Skills statement. Research students have representatives on all UEL research-related committees. This programme provides training including research governance, quantitative and qualitative research methods, research ethics and data analysis and processing. Students have formal weekly research team meetings; monthly monitoring sessions with their supervisory teams, and bi-annual, documented monitoring of their progress by the Graduate School. As part of the latter, students present and discuss their work, practising their presentation skills as they do so. Progression from MPhil to PhD at the end of the second year is dependent on a successful monitoring report. Each student has a Director of Studies and at least one UEL co-supervisor and highly experienced external advisors. The appointment of senior investigators with a high rate of successful PhD completions during their careers (Renton 3/3, Sacco 5/5, Turner 8/8) has consolidated the supervisory environment which has been enhanced by emeritus Cat B staff (e.g. Scott).
External research income earned by submitted staff is set to rise towards sector norms as a result of recent success since the audit date. The more experienced staff have strong evidence of previous external grant income (Cutler ca £2m; Renton ca £4m; Turner ca £0.3m) and it is expected that the number and size of external grant submissions will increase substantially in the next 24 months. For example since July 07, £9.5m has been secured for the GLA/Big Lottery funded “Well London Partnership” (Renton is the lead on £1.5m research work-plan at UEL); £7k has been secured for an EU COST evaluation (Cutler) and £20k for local NHS initiatives (Renton). Thus the recruitment strategy adopted has led to a coherent framework for successful submission of national and international grants and contracts in sustainable and long term collaborations with research partners. Submitted grants since July 2007 with outcomes pending, with such partners, include London School of Hygiene and Tropical Medicine (LSHTM; Aceijas; NIHR Service Delivery & Organisation Programme, £80k), local NHS initiatives (Renton; Redbridge; £120k), University of Delaware-USA (Drechsler and Petterson; NIH, US$5m), Imperial College London (ICL; Prostate Cancer Charity; Gannon, £100k) and Well London Partnership (Renton; Wellcome Trust £0.7m).
The research work of the IHHD includes areas of community health and wellbeing, sexual and mental health, rehabilitation and biomedical sciences.
HIV/AIDS research has been implemented through strong active partnerships between UK and overseas research teams and between multiple governmental and non-governmental stakeholders. A key focus of the programme has been on building local capacity for research and on developing sustainable links between policy-makers, clinicians, sociologists and community workers (International Journal of STD and AIDS, 17, 759-63, 2006). A growing focus of health research in this area is identifying and accessing information from hard-to-reach groups such as patients with urinary tract infections and drug users (Journal of Urban Health, 83, i39-i53, 2006). Building on his earlier work on the spread of Syphilis in Russia in the late 1990’s, Renton has led two programme of work aimed at understanding and mitigating the effects of HIV infection in developing and transitional countries, funded by the Dept. for International Development (DfID; £1.2m over 5 years from 2003 [Russia] and £800k over 5 years [Global]). Subsequently, further DfID funding (£50k in 2006) is providing for production of 10 policy briefs for Russian policy and decision makers. This work has resulted in a comprehensive series of economic, community health and policy oriented research publications combined in a single volume for DfID (summarised in Health Policy – doi:10.1016/j.healthpol.2007.07.005). The importance of this work has been recognized by the World Bank which has sponsored a series of further research studies in the Balkans and Central Asia (International Journal of Drug Policy, 17, 494-503, 2006), with Renton leading the research input to key Bank policy documents on HIV/AIDS (Working Paper 54: Priorities for HIV/AIDS Prevention in Central Asia, World Bank, Washington, 2005). Renton has also secured an extension to the DFID programme with Liverpool School of Tropical Medicine (£200K over 5 years). Renton’s work in the UK, transferring methods for participatory research on wellbeing and health in hard to reach, excluded and marginalised populations, has been published by London Health Commission (LHC) (reviewed in the LHC “Health in London” report, 2007). It provides the basis of a major new funded programme of work on health and wellbeing in deprived communities in London (Well London; £9.5m). Aceijas (previously project leader of the UN Reference Group on HIV prevention and care among IDU in developing and transitional countries at ICL and LSHTM) has developed and will continue studies on the global aspects of infectious, sexually transmitted diseases, especially HIV/AIDS, addressing preventative measures and promoting behavioural and political change (e.g. International Journal of Drug Policy, 18, 352-58, 2007).
A developing multidisciplinary research programme has been established and has focussed on psychiatric/psychological wellbeing, such as Renton’s work on the management of serious mental illness and the nature of comorbidity of psychiatric illness and substance misuse. Outcomes include the first qualitative studies to be carried out alongside a formal randomized controlled trial in psychiatry and detailed qualitative research explaining the lack of effect of intensive case management. Moreover, it has influenced the design of subsequent trials of complex interventions in psychiatry. Work with colleagues at ICL, supported by the Department of Health, has resulted in the first systematic prevalence studies of coincidence of mental health and substance misuse policy in the UK providing definitive evidence for development of services for comorbidity (Drug and Alcohol Review, 20, 407-416, 2001). Cahill’s continuing research in collaboration with the Institute of Psychiatry (Kings College London; KCL) also focuses upon developments in service provision for mental health patients. Outcomes include a valid and reliable mental health assessment tool - the Threshold Assessment Grid (TAG), used for referral purposes across a range of mental health services. The FOCUS randomized control trial was notable for its inclusion of the patient and practitioner as raters of mental well-being and had positive impacts on reduced admission rates. The TAG and FOCUS studies are also notable for teaching practitioners how to use standardised assessments longitudinally, which is not normal practice in mental health research or necessarily in everyday clinical practice. McDermott’s research is focused upon individual differences as psychosocial antecedents of ill health and applications of social cognition models to the prediction of paradoxical health behaviours. Research in coronary artery disease (CAD) confirmed that the anger-hostility complex is reducible to only two dimensions (anger in and out) and that frequently expressed anger is the coronary toxic component of the anger hostility complex and indeed of the Type A/Type B behavioural pattern. A randomized control trial (RCT) evaluated an evidence-based and extended Theory of Planned Behaviour (TPB) driven intervention and produced a reduction in Friday night alcohol consumption amongst women drinkers and has prompted future research on health promotion in a high risk section of the community. Gannon’s work focuses on men’s health, including prostate related problems, especially with regards to understanding the impact of lower urinary tract symptoms (LUTS) resulting from benign enlargement. The ongoing main objectives of this research are to develop a greater understanding of such problems in order to delay or avoid the need for surgical intervention.
There is a strong research programme of neurological, cognitive and musculoskeletal rehabilitation significantly enhanced by recent appointments. For example, preliminary work from Sacco and Turner with international collaborators is published and highlights the rapid development of novel neurorehabilitation techniques such as motor learning in robot-induced force fields (J. Physiology, P3, C9, 2006), paired magnetic brain stimulation (with Institute of Neurology, University College London /UWA-AUS in Clinical Neurophysiology, 117, S110, 2006) and direct current brain stimulation (with Univ Gottingen, FRG; 2007 Society of Neuroscience Meeting: Abst 82.24/LL8). In partnership with local NHS end-users, a clinical trial using robot-aided rehabilitation is now being incorporated into existing therapy programmes in stroke rehabilitation units (Newham UHT Stroke Care Pathway). The potential of this work is evidenced by Sacco and Turner being invited to be primary partners in a UK robot-aided neurorehabilitation collaborative group. This work is already informing national NHS policy development, with Turner, a key contributor in compiling a consensus/policy report on stroke rehabilitation methods which will revolutionalize UK practice (Wellcome Trust funded MasterClass in Neurosciences – “Restorative Neurology and Stroke Rehabilitation”, Sept 07). In addition to establishing the stroke robot-rehabilitation pathway with local NHS Trusts, Sacco will continue using these techniques to study cortical function in multiple sclerosis and chronic fatigue syndrome in an international collaboration with UWA-AUS (Research in Sport Medicine, 15, 47-59, 2007). Rose’s complementary research focuses on Virtual Reality (VR) applications in cognitive rehabilitation after brain damage and combining VR with Functional Magnetic Resonance Imaging (fMRI) at Inst. of Psychiatry (KCL) to examine spatial memory after brain injury. This line of research has significant implications for the capacity to accurately predict and rehabilitate the particular memory impairments that patients are likely to experience following brain injury (work in collaboration with the Regional Brain Injury Unit at the Homerton Foundation Hospital, London; RBIU). This work has been extended into looking at VR as a tool for assessment of brain damage induced impairments (stroke), and for the rehabilitation and training people with learning disabilities (funded by MENCAP and reviewed in collaboration with Rizzo, Univ. Southern California [USC] in Cyberpsychology and Behaviour, 8, 241-262, 2005). The collaborative multidisciplinary techniques used by Rose, Sacco, Turner and Rizzo for brain monitoring and stimulation and robotics are being combined with the VR cognitive training in a specially developed core-funded brain rehabilitation unit. Drechsler and Petterson lead a musculoskeletal rehabilitation research programme assessing gait disturbances during stair climbing in young and old and interventions for pre- and post-knee replacement following arthritis, in partnership with international collaborators at Univ. Delaware, USA. A large, 4 year study with the Regional Centre for Haemophilia (based at Canterbury NHS Trust, Kent; funded by the Haemophilia Society, £25k) started in 2006, following the impact on quality of life of haemophilia-induced ankle joint dysfunction in 7-12 year olds with primary results already disseminated (International Society of Biomechanics Abstract, 20th Meeting, 2006).
Rehabilitation research also includes a long term programme of high impact work in the development of therapeutic exercise-based interventions. For example, Turner developed cellular electrophysiological models of bone and muscle adaptation to voluntary exercise interventions (Journal of Experimental Biology, 204, 1191-1199, 2001). The series of studies yielded novel electro-mechanical mechanisms responsible for several types of myocardial cellular adaptation and possible dysfunction, such as that occurring during exertion-induced sudden death in young athletes (funded originally by CAPES-Brazil; £80k). RCT-based studies by Scott, also in collaboration with the RBIU, detailed the physical capacity for exercise in brain-injured patients and positive adaptations in cardiovascular and musculoskeletal systems after endurance training (Scott; Arch. Phys. Med. Rehabilitation, 82, 174-82, 2001) and strength training (Scott; Disability and Rehabilitation, 28, 883-9, 2006) in young, severely brain injured patients (funded originally by the Stroke Association). Successful rehabilitation of these young patient groups has a large impact on reducing health costs and loss of productivity in the workplace.
There is a focussed research programme aimed at a better understanding of several diseases and syndromes which will inform better designed preventive interventions, rehabilitation and health protection. Renton has carried out research funded by The Wellcome Trust (£102k) identifying appropriate diagnostic tests for sexually transmitted infections in both the UK and abroad for example in pregnancy (International Journal of STD and AIDS, 17, 443-7, 2006). This line of work has also led to revision of guidelines to promote culture diagnosis and reduce use of provocation in several countries of the former Soviet Union. Cutler has built on her previous programme at the Veterinary Laboratories Agency (VLA) to look at Brucellosis in Peru and in Kenya. The latter is undertaken in collaboration with the University of Edinburgh (reviewed in Journal for Applied Microbiology 98, 1270-81, 2005). This work, currently progressing through the sequencing of genomes of B. recurrentis and B. duttonii first isolated by Cutler, has resulted in international presentations and £7k (Society for General Microbiology) has been granted to host a meeting in an endemic area in Tanzania to further promote locally-based research. Similarly, laboratory research has benefited from the recent appointments. Research interests and collaborations include: immunological mechanisms of disease such as inflammatory heat syndromes (Ahluwalia with ICL & UCL; e.g. Neuroscience, 110, 747-53, 2002) and toxic shock and autoimmune disease (Terrazzini with UCL; reviewed in Molecular Immunology, 38, 997-1002, 2001). Corcoran’s research collaboration with KCL has focussed on the development of innovative hyphenated technologies for further understanding the immune response that elicits common adverse reactions to anti-inflammatory drugs (reviewed in Drug Discovery Today, 8, 624-631, 2003). Together the established researchers and the ECRs, who they mentor, will form the basis of a sustainable expansion of research focussed on the study of disease mechanisms of major economic and health impact.
Promoting and Developing Research
In addition to developing research through recruitment of ECRs, postdoctoral researchers and MPhil/PhDs, there are several mechanisms and practices aimed at promoting and sustaining a research culture. These include: staff appraisal to provide support for academic staff to enhance their research activity; regular workshops and residential events to provide research training and support development of plans to concentrate and focus research effort; research seminar series; and effective staff development programme through sabbaticals, career review and funded national and international conference attendance; the management and implementation of collaborative research programmes; support of project teams to generate external funding to build capacity and oversee governance and strategic planning. Allowances are made for success of research activities reported in annual reviews and significant remission from teaching and administrative duties are made as appropriate to foster growth. Furthermore, participation in COST Actions and Robot User Groups (mentioned above) facilitate exchange visits to other laboratories within Europe and USA to build technical expertise across collaborations.
A key aspect to the continuing development of research relevance has been an active policy of collaboration with end-users as well as other research groups. Senior researchers have joint contracts and long-term research collaborations with NHS partners (Renton with London SHA; Turner as external specialist on Newham NHS Trust Research and Development Board). The inclusion of end-users in the research networks enhances the operations of the IHHD, ensures that research undertaken is relevant to end-users and encourages political and financial support for future funding applications. One example of this is the orchestrated effort to address the major health issues that exist in the communities of the East London and Thames Gateway region, the largest regeneration zone in Europe. Several members actively participate in forming health strategies for the region (Renton; lead on “2012 Health Legacy” Dept. Health Workstream 5 - Monitoring, Evaluation and Research Group) as well as strategies for the post 2012 Games Legacy use of the Olympic Park infrastructure (Turner; member of Olympic Delivery Authority [ODA] Working Group of Stadium Stakeholders).
The research team has benefited from the investment in superb facilities and state-of-the-art equipment [£4m; nonSRIF funding, 2004-2007]. Major new equipment includes upper limb rehabilitation robotics (The only UK-based InMotion2 shoulder/upper arm robot; SensAble PHANToM haptic devices for wrist/hand rehabilitation), a 3D Immersion virtual reality suite, neurophysiological systems for EEG (128 channel Geodesic) and transcranial stimulation (multipulse Magstim and direct current stimulators) supporting the published work of Rose, Sacco and Turner. The biomechanics suite has a 10 camera system (Vicon), multiple force plates (Kistler) and foot pressure systems (F Scan), ultrasound equipment (DiaSys), clinical/mixed ability treadmill and state-of-the-art isokinetic dynamometers (Biodex and SRM) to support the published work of Drechsler and Petterson. Substantial investment in genomic/proteomic and cellular and ion channel electrophysiological equipment (e.g. RT-PCR, MALDI-TOF) supports the published research of Ahluwalia, Corcoran and Cutler and offers a platform for a significant enhancement of biomedical research with industrial partners.
Research is already beginning to benefit from the regional regeneration-related opportunities, with a significant proportion of research undertaken in a new state-of-the-art and equipped Clinical Centre that was opened in 2006 (£2.5m) and in part funded by local NHS Trusts, PCTs and professional bodies for Podiatric Medicine and Physiotherapy. Special note is made of the relocation of the London Foot Hospital to UEL in 2005 which provides opportunities to develop further musculoskeletal research. Ferrari, Morrison and Rees (all ECRs) undertake this research programme with clinical collaborators at Medway, West Middlesex and Great Ormond Street Hospital for Children NHS Trusts. The Scholl Foundation Endowment, with a fund of some £3m has been set up to enhance podiatry research at UEL and Turner is a member of the governing board. Recent ECR recruitment has focussed research on the effect of obesity and load bearing on gait and posture in children (Morrison; start 03/06; Gait and Posture doi:10.1016/j.gaitpost.2007.09.003), foot surgery outcomes (Rees; start 05/04; Journal of Foot and Ankle Surgery, 46, 80-85, 2007) and for bunions (Ferrari; start 09/03; reviewed in Cochrane Database of Systematic Reviews 2004, vol. 1 No. CD000964). Furthermore, Ferrari and Morrison have recently been presented the Canonbury Prize (£5k) for research on gait-related aspects of developmental coordination disorder in childhood. The early research success of these ECRs will become the basis for forming a leading UK Podiatry Research Group in the next 5 years.
Policy & Practice in Research Governance
The senior professorial research team with the postgraduate training programme leader (with affiliated Research Strategy and Degrees Committees) is responsible for the Policy and Practice for Research Governance. All research projects and programmes are subjected to UEL Ethics Approval in parallel with project ethical approval from our clinical Trust collaborators. There is internal review of projects and grant applications by senior researchers in order to assert that participants’ rights are protected, that appropriate health and safety guidelines are strictly adhered to and FEC financial guidelines are followed.
The IHHD has benefited recently by attracting professorial (Renton from ICL and Turner from Surrey-Roehampton), established researchers (Cutler from VLA and Sacco from UWA) and a team of very promising ECRs (Ahluwalia from UCL, Cahill and Corcoran, both from KCL and Petterson from Univ. Delaware). In the short time since these staff arrived, the publication record has expanded significantly and the longer term grant income is set to rise through a greater quantity and quality of applications (see earlier). Further Professorial appointments in Exercise Health Sciences and Community and Family Health will push forward the IHHD roles in research regarding the impact of both 2012 Games and urban regeneration programmes. Renton is the Director of IHHD and Turner is acting Director of the new Centre for Disability, Exercise and Health and together they now lead the integration of health-related research across UEL.
ECRs, postdoctoral research fellows (Wall, Tobi, Getti) and PhD students work in research teams and are mentored by “established investigators”, mirroring the recent recommendations in NIHR guidelines. Several emeritus positions held by Category B staff (Beeston, Garbutt, Gharbia, Humber and Scott) and visiting research professors (Snyder-Mackler, Univ. Delaware) offer substantial expertise in co-supervision of PhD students, mentoring ECRs and offering advice on project design using their wealth of networking opportunities.
A main priority for the next 5 years is to continue to build on the growth in research activities since 2001 and particularly since 2005 to further increase research capacity and output. The context of a significant proportion of research is already oriented towards the build-up to and legacy of the 2012 Games (e.g. Well London Partnership; http://www.londonshealth.gov.uk/well_london.htm). The research will continue to be focussed on the application of basic clinical and public health sciences to improve the physical and mental quality of life of individuals, neighbourhoods and hard-to-reach communities. IHHD will continue to build on the research expertise already existing within the affiliated NHS Trusts, London SHA, international health fields and social medicine networks but with greater emphasis on securing funds from Research Councils and Charities. Clinical academic ECR posts with joint appointments at local NHS Trusts have already set up research discussion groups with clinicians in order to inform their research programme development. The IHHD will therefore necessarily continue to involve a high level of practice-based and end-user orientated research.
Another main objective for the next five years is to increase external income, such that the external income for each researcher will increase towards sector norms in the next period from @£50k to >150k through the targeting of the most likely sources of external income and utilising existing and new international, national and local collaboration to strengthen bids to research councils and charities. In addition, greater use will be made of existing strengths and networks in multidisciplinary and interdisciplinary/translational approaches to raising income. It is expected that the primary partnership that UEL holds with the ODA/LOCOG of the 2012 Games [notwithstanding the location of IHHD/Stratford Campus in the Olympic Park Zone thereby inheriting improved premises including world-class exercise facilities] will provide further opportunities for health and clinical research, especially in areas related to exercise science, physiotherapy and public health. Our new Professorial posts will strengthen this strategy. UEL is in an ideal position to benefit both directly and indirectly through the potential for further international and national collaboration in conjunction with several successful UK bids for future world sporting events over the next decade. These exciting prospects are in addition to external income arising from the Thames Gateway Regeneration Zone.
The final main objective for the next period is to increase the number of PhD students and completions per staff researcher. Thus, funding for 12 bursaries (3 per year to support the recruitment of PhD students is planned for 2008-11. It is expected that will be in addition to those funded by external sources which is expected to average 2 per year in the period.
We believe that this strategy and ambition is realistic, and on the evidence of our recent success we can expect to deliver major increases in funding which will underpin consolidation of research, carried out in collaboration with renowned international and national research partners whilst engaging locally based end-users. This in turn will lead to increased citations in publications in top journals and an established research training environment. This represents a substantial, step-change enhancement of the research profile from the previous RAE period.
Examples of specific markers of esteem not mentioned thus far in narrative are highlighted alphabetically for each esteem indicator here:
Invited addresses at National & International conferences / centres of excellence:
Cutler: Congress of the European Society of Emerging Infections (ESEI), Portugal 2007 and Marseilles 2006.
“Guest of Honour” at 2nd International meeting on TBRF, Mvumi Hospital, Tanzania, 2003.
Renton: Scientific Meeting of the International Union against Sexually Transmitted Infections. Mykonos 2004.
Plenary Session, Infectious Diseases Society of America Annual Scientific Conference. San Francisco 2001.
Rose: Keynote talk. The use of virtual reality in brain injury rehabilitation. Conference: The Brain Injury Rehabilitation Trust 2005.
Invited public seminars: Cahill World Psychiatric Association, Spain (2001); Corcoran New Delhi, India (2006), KCL (2006); Cutler Royal College of Pathologists (2004) Haartman Institute, Finland (2004); Gannon Royal College of Surgeons (2001); Turner UW Madison, USA (2005), Southampton (2006), Birmingham (2007).
Influence on International and National government policy:
Aceijas is leader of the UN Reference Group on HIV prevention and care among IDU in developing and transitional countries.
Renton has influenced UN/World Bank papers/policy (see narrative); membership of United Nations Task Force for the Urgent Response to the Epidemics of Sexually transmitted Infections in Eastern Europe and Central Asia; membership of the Health Protection Agencies Advisory Group on Sexually Transmitted Diseases, HIV Infection and AIDS; writing a major section of the 2007 Health in London Report.
Influence of research on International and National practice:
Cahill co-wrote Good practice guidelines for identifying the priority group for specialist mental health services, London: Threshold Programme. 2002 (Distributed to all Mental Health Trust CEOs and Social Service Directors in England).
Service on government International and National bodies or advisory bodies:
Cahill contributed to The FOCUS Study, 1st Croydon Research Forum, London (2001);
Renton has served on UN Task Force for the Urgent Response to the Epidemics of Sexually transmitted Infections in Eastern Europe and Central Asia and Health Protection Agencies Advisory Group on Sexually Transmitted Diseases, HIV Infection and AIDS. He is leader of the monitoring evaluation and research work-stream for the Department of Health 2012 Health Legacy Programme.
Gannon; Joint Editor and International Advisory Board for Journal of Reproductive and Infant Psychology.
Renton: Member of Editorial Boards for Sexually Transmitted Infections and Sexually Transmitted Infections (Russia).
Rose: Member of Editorial Board for Developmental Neurorehabilitation and CyberPsychology and Behaviour; Guest Editor (Special Edition of Cyberpsychology and Behaviour on the use of virtual environments in training and rehabilitation. Vol. 8, 2005).
Indicators of esteem from the user community:
- Ongoing Grant reviewing activities;
Corcoran: Norwegian Research Council
Renton: MRC; Wellcome Trust.
McDermott: Research Council for Culture & Society (Finland); Alcohol Education & Research Council (UK).
Turner: USDA and NIH, USA; The Stroke Association (UK).
- Ongoing Journal Reviewing Activities;
Corcoran: Chirality, Drug Discovery Today, FEBS Letters, Environmental Science and Technology
McDermott: Journal of Health Psychology, British Journal of Social Psychology
Sacco: Clinical Neurophysiology, European Journal of Applied Physiology, Journal of Applied Physiology, Clinical Science, Muscle and Nerve.
Turner: Brain Research, Cognitive Brain Research, Journal of Physiology, European Journal of Applied Physiology, Respiratory Neurobiology and Physiology.
Corcoran: Visiting Research Fellow at King's College London, Department of Pharmacy.
Cahill: Trustee for Woman’s Health Concern (Charity).
Cutler: On Organising Committees for Brucella VNTR workshop (2006); Third International Meeting on Tick-borne relapsing fever (2007) in Tanzania; Honorary chair of the Bulgarian Medical Association.
Rose: Visiting Professor of Neuropsychology, Royal Hospital for Neurodisability, Putney. London (2001-2003).
Sacco: Honorary Research Fellow at Centre for Neuromuscular and Neurological Disorders
University of Western Australia, Australia.
Evidence of collaboration with research centres outside the UK:
Aceijas: Member of the Scientific Committee of Institute for the Study of Addictions, University of Valencia. Spain
Corcoran: University of Cape Town SA; University of Copenhagen.
Cutler: projects in France, Portugal, Israel, Iraq. External supervisor of PhD student Christer LARSSON, (currently based in Sweden); International Advisor for a project “Monitoring of Human and Animal Brucellosis in Kazakhstan” 2007 onwards;
Renton: Russian Academy of Medical Science, HEARD, University of Natal at Durban SA, University Intellung Antwerp, Belgium, Yale University USA (Joint NIH grant).